Changhong Liu1, Fengzhe Chen2, Xiaochun Han3, Hui Xu4, Yiguo Wang1. 1. Department of Gastroenterology, Qianfoshan Hospital Affiliated to Shandong University Jinan 250014, Shandong, China. 2. Department of Infectious Diseases, Qilu Hospital of Shandong University Jinan 250012, Shandong, China. 3. Department of Preventive Medicine, Shandong University of Traditional Chinese Medicine Jinan 250013, Shandong, China. 4. School of Medicine and Life Sciences, University of Jinan-Shandong Academy of Medical Sciences Jinan 250062, Shandong, China.
Abstract
OBJECTIVE: This study is to investigate the hepatitis B virus (HBV)-induced tubular epithelial-myofibroblast transdifferentiation (TEMT) in human renal tubular epithelial HK-2 cells. METHODS: Human proximal tubular epithelial HK-2 cells were cultured. These HK-2 cells were divided into 4 groups: the blank control group, the vector control group, the HBV-transfected group, and the inhibitor-treated group. Transfection was performed with lipofectamine. Measurements of hepatitis B e antigen (HBeAg) and hepatitis B surface antigen (HBsAg) in culture supernatant were determined by electrochemiluminescence immunoassay. Immunocytochemical staining, reverse transcription PCR (RT-PCR), and Western blot analysis were performed to detect the mRNA and protein expression levels, respectively. RESULTS: The immunocytochemical staining showed that, the expression level of E-cadherin was dramatically decreased, while the α-SMA expression level was significantly elevated, in HBV-transfected HK-2 cells. The mRNA level of TGF-β1 and the protein level of p-p38 mitogen-activated protein kinase (MAPK) were elevated in HK-2 cells transfected with HBV. When treated with the p38 MAPK-specific inhibitor, the activation of p38 MAPK was eliminated in HBV-transfected HK-2 cells. In addition, the altered expression levels of E-cadherin and α-SMA, the increased contents of HBeAg and HBsAg in the culture supernatant, as well as the morphological changes of TEMT in HBV-transfected HK-2 cells, were all reversed by the inhibiter treatment. CONCLUSION: HBV transfection could induce TEMT in HK-2 cells, which was mediated by the TGF-β1/p38 MAPK pathway. These findings provide new insights into the prevention and treatment of HBV-associated glomerulonephritis.
OBJECTIVE: This study is to investigate the hepatitis B virus (HBV)-induced tubular epithelial-myofibroblast transdifferentiation (TEMT) in human renal tubular epithelial HK-2 cells. METHODS:Human proximal tubular epithelial HK-2 cells were cultured. These HK-2 cells were divided into 4 groups: the blank control group, the vector control group, the HBV-transfected group, and the inhibitor-treated group. Transfection was performed with lipofectamine. Measurements of hepatitis B e antigen (HBeAg) and hepatitis B surface antigen (HBsAg) in culture supernatant were determined by electrochemiluminescence immunoassay. Immunocytochemical staining, reverse transcription PCR (RT-PCR), and Western blot analysis were performed to detect the mRNA and protein expression levels, respectively. RESULTS: The immunocytochemical staining showed that, the expression level of E-cadherin was dramatically decreased, while the α-SMA expression level was significantly elevated, in HBV-transfected HK-2 cells. The mRNA level of TGF-β1 and the protein level of p-p38 mitogen-activated protein kinase (MAPK) were elevated in HK-2 cells transfected with HBV. When treated with the p38 MAPK-specific inhibitor, the activation of p38 MAPK was eliminated in HBV-transfected HK-2 cells. In addition, the altered expression levels of E-cadherin and α-SMA, the increased contents of HBeAg and HBsAg in the culture supernatant, as well as the morphological changes of TEMT in HBV-transfected HK-2 cells, were all reversed by the inhibiter treatment. CONCLUSION:HBV transfection could induce TEMT in HK-2 cells, which was mediated by the TGF-β1/p38 MAPK pathway. These findings provide new insights into the prevention and treatment of HBV-associated glomerulonephritis.
Entities:
Keywords:
Hepatitis B virus (HBV); TGF-β1/p38 MAPK pathway; human tubular epithelial cells; tubular epithelial-myofibroblast transdifferentiation (TEMT)
Authors: Cosimo Stambe; Robert C Atkins; Greg H Tesch; Takao Masaki; George F Schreiner; David J Nikolic-Paterson Journal: J Am Soc Nephrol Date: 2004-02 Impact factor: 10.121